Accéder au contenu
Merck

Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.

Journal of medicinal chemistry (2012-01-20)
Justin I Montgomery, Matthew F Brown, Usa Reilly, Loren M Price, Joseph A Abramite, Joel Arcari, Rose Barham, Ye Che, Jinshan Michael Chen, Seung Won Chung, Elizabeth M Collantes, Charlene Desbonnet, Matthew Doroski, Jonathan Doty, Juntyma J Engtrakul, Thomas M Harris, Michael Huband, John D Knafels, Karen L Leach, Shenping Liu, Anthony Marfat, Laura McAllister, Eric McElroy, Carol A Menard, Mark Mitton-Fry, Lisa Mullins, Mark C Noe, John O'Donnell, Robert Oliver, Joseph Penzien, Mark Plummer, Veerabahu Shanmugasundaram, Christy Thoma, Andrew P Tomaras, Daniel P Uccello, Alfin Vaz, Donn G Wishka
RÉSUMÉ

The synthesis and biological activity of a new series of LpxC inhibitors represented by pyridone methylsulfone hydroxamate 2a is presented. Members of this series have improved solubility and free fraction when compared to compounds in the previously described biphenyl methylsulfone hydroxamate series, and they maintain superior Gram-negative antibacterial activity to comparator agents.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3-Pyridinylboronic acid, ≥95.0%
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
RéférenceConditionnementDisponibilitéPrix
10 mg
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
97,60 €
50 mg
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
355,00 €

To order products, please contact your local dealer.